Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
NeuroPace, Inc.

NeuroPace, Inc. (NPCE) Stock Overview

Explore NeuroPace, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NPCE●NASDAQ
HealthcareMedical - Devices
$14.51
$0.05(0.34%)
U.S. Market opens in 3h 6m

NeuroPace, Inc. (NPCE)

Meyka AI Score

Z

Key Financials

Market Cap494.7M
P/E Ratio-25.61
EPS (TTM)$-0.65
ROE-1.20%
Fundamental Analysis

AI Price Forecasts

1 Month$15.43
3 Months$15.85
1 Year Target$17.29

NPCE Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of NeuroPace, Inc. (NASDAQ: NPCE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, NeuroPace, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NPCE on the NASDAQ shows an RSI of 46.41, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $17.29 for the NASDAQ listing.

Key metrics behind NeuroPace, Inc.'s NASDAQ-traded stock include a P/E ratio of -25.61 and a market capitalization of 494.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NPCE on the NASDAQ.

Price Performance (NASDAQ: NPCE)

1-Day Change
-0.34%
5-Day Change
3.87%
1-Month Change
-15.25%
3-Month Change
-8.22%
6-Month Change
-3.59%
Year-to-Date (YTD) Change
-6.02%
1-Year Change
55.69%
3-Year Change
224.61%
5-Year Change
-29.39%
All-Time (Max) Change
-41.87%

Contact Information

https://www.neuropace.com
650 237 2700
455 North Bernardo Avenue, Mountain View, CA, 94043

Company Facts

2,090 Employees
IPO DateApr 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions